Aileron Therapeutics Unveils New Therapeutic Drug Program; Appoints Hubert C. Chen, M.D., to Vice President of Clinical Development
07:30 EDT 6 Sep 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Aileron
Therapeutics, Inc. today announced the appointment of Hubert C.
Chen, M.D., to vice president of clinical development, endocrine and
metabolic disease. This strategic appointment comes as Aileron expands
into endo...
Other Sources for this Article
Pure Communications, Inc.
Sheryl Seapy, 949-608-0841
More From BioPortfolio on "Aileron Therapeutics Unveils New Therapeutic Drug Program; Appoints Hubert C. Chen, M.D., to Vice President of Clinical Development"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
